Skip to content
Screener

Denali Therapeutics Inc. DNLI Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Williams Companies logo
Williams CompaniesWMB
$3.77B+11.5%
Rockwell Automation logo
Rockwell AutomationROK
$590M-3.9%
Taboola.com Ltd. logo
Taboola.com Ltd.TBLA
$298.97M+13.4%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$99.36M+94.2%
Dynatrace logo
DynatraceDT
$16.29M-97.3%
Eos Energy Enterprises, Inc. logo
Eos Energy Enterprises, Inc.EOSE
$686K

Other financials

Income statement

See full
Revenue$3.6M
Gross profit$3.5M
Operating income-$130.5M+3.3%
Net income-$127.6M-2.8%
EPS (diluted)-$0.68+5.6%

Balance sheet

See full
Cash & equivalents$204.6M+41.8%
Total debt$37.7M-21.4%
Total equity$835.2M-18.7%
Total assets$1.2B-0.7%

Cash flow

See full
Operating cash flow-$97.0M-28.8%
CapEx$805.0K-81.2%
Free cash flow-$97.8M-22.9%

Valuation

See full
Market cap$3.97B+96.3%
Enterprise value$3.8B+97.4%
P/S1,101.3×+1,096×

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-54.9%+34.3pp
Debt / equity0.0×
Current ratio8.4×-1.9×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001714899-26-000097

The Company recognized amortization expense of $0.7 million for the three and six months ended June 30, 2026. As of June 30, 2026, the accumulated amortization expense was $0.7 million, and the carrying value of the intangible asset was $35.3 million.

Item 1. Financial Statements (Unaudited)

FAQ

What is Denali Therapeutics Inc.'s finite-lived intangible assets, accumulated amortization?
Denali Therapeutics Inc. (DNLI) reported finite-lived intangible assets, accumulated amortization of $700K in Q2 2026.
What does finite-lived intangible assets, accumulated amortization mean?
Finite-Lived Intangible Assets, Accumulated Amortization

Ask your AI about Denali Therapeutics Inc.'s finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude